BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6707341)

  • 1. Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure.
    Walsh RW; Porter CB; Starling MR; O'Rourke RA
    J Am Coll Cardiol; 1984 Apr; 3(4):1044-50. PubMed ID: 6707341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
    Materne P; Legrand V; Vandormael M; Collignon P; Kulbertus HE
    Am J Cardiol; 1984 Oct; 54(7):733-7. PubMed ID: 6486022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
    Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of diltiazem and nitroprusside on left ventricular function in experimental chronic volume overload.
    Porter CB; Walsh RA; Badke FR; O'Rourke RA
    Circulation; 1983 Sep; 68(3):685-92. PubMed ID: 6872178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.
    Amodeo C; Kobrin I; Ventura HO; Messerli FH; Frohlich ED
    Circulation; 1986 Jan; 73(1):108-13. PubMed ID: 3510085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic tolerability and anti-ischemic efficacy of high dose intravenous diltiazem in patients with normal versus impaired ventricular function.
    Remme WJ; Krauss XH; van Hoogenhuyze DC; Kruyssen DA
    J Am Coll Cardiol; 1993 Mar; 21(3):709-20. PubMed ID: 8436753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
    Soward AL; Vanhaleweyk GL; Serruys PW
    Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared.
    Nakaya H; Schwartz A; Millard RW
    Circ Res; 1983 Mar; 52(3):302-11. PubMed ID: 6825222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Verapamil, diltiazem or nifedipine in severe left ventricular functional disorder? A comparative study of the immediate hemodynamic effects].
    Figulla HR; Kreuzer H; Luig H
    Dtsch Med Wochenschr; 1986 Jan; 111(1):11-4. PubMed ID: 3940829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure.
    Elkayam U; Weber L; Torkan B; Berman D; Rahimtoola SH
    Am J Cardiol; 1983 Nov; 52(8):1041-5. PubMed ID: 6637820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of intravenous diltiazem in patients with recent myocardial infarction.
    Koiwaya Y; Takeshita A; Nakamura M
    Clin Ther; 1982; 4(5):381-9. PubMed ID: 7066936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure.
    Ferlinz J; Citron PD
    Am J Cardiol; 1983 May; 51(8):1339-45. PubMed ID: 6846161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic, left ventricular and coronary hemodynamic effects of intravenous diltiazem in coronary artery disease.
    Joyal M; Cremer KF; Pieper JA; Feldman RL; Pepine CJ
    Am J Cardiol; 1985 Sep; 56(7):413-7. PubMed ID: 4036821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
    Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.
    Kates RA; Zaggy AP; Norfleet EA; Heath KR
    Anesthesiology; 1984 Jul; 61(1):10-8. PubMed ID: 6742468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
    Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
    J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of intravenous diltiazem in patients with acute myocardial infarction.
    Ogawa H; Yasue H; Nakamura N; Obata K; Sonoda R
    Clin Cardiol; 1987 Jun; 10(6):323-8. PubMed ID: 3594955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.